Vertex Reports Third-Quarter 2018 Financial Results

Go back to Vertex Reports Third-Quarter 2018 Financial Results

Vertex (VRTX) PT Lowered to $204 at RBC Capital

October 25, 2018 7:43 AM EDT

RBC Capital analyst Brian Abrahams lowered the price target on Vertex (NASDAQ: VRTX) to $204.00 (from $208.00) while maintaining a Outperform rating.

... More

Vertex Pharma (VRTX) Tops Q3 EPS by 7c

October 24, 2018 4:02 PM EDT

Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.09, $0.07 better than the analyst estimate of $1.02. Revenue for the quarter came in at $783.9 million versus the consensus estimate of $790.91 million.

For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.

... More